Novartis Group News Monitoring

Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-...

Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant and clinically meaningful benefit for Pluvicto™ plus hormone therapy versus hormone therapy alone, with positive …

Novartis' Pluvicto shown to slow prostate cancer in earlier setting

FRANKFURT (Reuters) -Novartis said on Monday that its targeted radiotherapy Pluvicto was shown to slow progression of a certain type of prostate cancer, raising the prospect of treatment in an earlier disease stage for a drug technology that the drugmaker …

Novartis announces data from new subgroup analysis of Phase III NATALEE trial

Novartis (NVS) is announcing data from a new subgroup analysis of the Phase III NATALEE trial evaluating the efficacy and safety of Kisqali plus endocrine therapy in patients with stage II and III hormone receptor-positive/human epidermal growth factor …

Rx Rundown: Novartis, iTeos Therapeutics, Moderna and more

Deals: Novartis launched a tender offer for Regulus Therapeutics. Biogen and City Therapeutics announced a partnership to develop a drug for an undisclosed central nervous system disease. Eli Lilly bought SiteOne Therapeutics. Blackstone’s GRIN inked an …

Alcon gains first FDA prescription drug nod since Novartis split, scoring with drops for dry eye disease

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first FDA approval for a prescription drug, scoring a nod for dry eye disease (DED) treatment Tryptyr (acoltremon ophthalmic solution). …

Heart health is a shared responsibility, says Novartis India head

Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019

The U.S. Food and Drug Administration (FDA) on Wednesday approved Alcon Plc’s ALC Tryptyr (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for signs and symptoms of Dry Eye Disease (DED). Alcon produces contact lenses, dry eye drops, …

Novartis emerged victorious in multi-month pursuit of Regulus and potential kidney blockbuster, filing shows

Novartis’ $1.7 billion Regulus Therapeutics buyout last month came after a hard-fought battle in which the Swiss pharma and another interested party raised the stakes several times, a new securities filing shows. Regulus’ autosomal dominant polycystic …

Former Chinook Board Member Indicted for Insider Trading Related to $3.2B Novartis Buy

The Department of Justice last week charged five people for allegedly participating in securities fraud in connection with Novartis’ $3.2 billion acquisition of Chinook Therapeutics in June 2023. Among those indicted is Rouzbeh “Ross” Haghighat, who was on …

Wearing Off Rates Higher in Ocrelizumab Than Ofatumumab, Study Suggests

Findings from a non-interventional primary data collection study of adults with multiple sclerosis (MS) showed that significantly higher patients on ocrelizumab (Ocrevus; Genentech) experienced wearing off related symptom worsening while on medication than …

Stratus Therapeutics Strengthens Executive Team with Appointment of Michael P. Cooke, PhD as Chief Scientific Officer

CAMBRIDGE, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Stratus Therapeutics, Inc. (“Stratus”), a biotechnology company developing on-demand hematopoietic stem cell (HSC) therapies, today announced the appointment of Michael (Mike) P. Cooke, PhD, as Chief …

06.02.25 -- Cell & Gene Therapy Manufacturing: Considerations For Early-Stage Companies

Join the 5th Next Generation Gene Therapy Vectors Summit in 2025 — the only industry-led event dedicated to rational vector selection and engineering. Hear from experts at Novartis, Spark, 4DMT, and Coave on improving targeting, reducing immunogenicity and …

Trump’s Pharmaceutical Tariffs Are Not the Right Solution for a Big Problem

President Donald Trump has threatened to impose 25 percent tariffs on pharmaceutical imports, the fourth largest contributor to America’s trade imbalance, after machinery and electrical equipment and automobiles. A vast majority of these imports are low- …

Global Shared Services Center Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034

The Business Research Company's Shared Services Center Global Market Report 2025 – Market Size, Trends, And Global Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The shared services center …

European Shares Mostly Lower Amid Global Trade Tensions

European stocks were broadly lower on Monday as U.S. President Donald Trump's decision to double tariffs on steel and aluminum imports along with rising Sino-U.S. tensions threatened to rekindle global trade tensions. In economic releases, the downturn …

REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202

Event will feature Aravindhan Veerapandiyan, M.D., principal investigator of the AFFINITY DUCHENNE® trial ROCKVILLE, Md., June 2, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a webcast to discuss new interim …

Digital Dose Inhalers Market Growth 2024 - 2031 | Insights By DataM Intelligence - Your Partner in Data-Driven Insights

The Digital Dose Inhalers Market is set for strong growth through 2031, driven by rising respiratory diseases and demand for smart, accurate drug delivery. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Digital Dose Inhalers Market …

Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development

MELBOURNE, Australia and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifying immunotherapies for food allergy, today announces the appointment of Louise …

iOnctura bolsters leadership team with new appointments

Steven Sciuto joins as Chief Financial Officer (CFO) bringing a wealth of experience in scaling finance functions as well as in private and public financings Michelle Tsai PharmD, with deep expertise in portfolio strategy and lifecycle planning, joins as …

New Documentary Highlights Advances in Headache Research and Offers Hope to Billions

The International Headache Society (IHS) is set to launch the documentary series Headed for the Future at the start of Migraine Awareness Month. LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The International Headache Society (IHS) is set …

The Freedom Center Expands Access to Outpatient Addiction Treatment in Maryland

Through a range of outpatient care options, the center offers structured support for individuals managing substance use and co-occurring mental health disorders GAITHERSBURG, MD, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Freedom …

Closed System Drug Transfer Devices Market Size, Trends, Share & Forecast 2025 | DataM Intelligence

The Global Closed System Transfer Devices (CSTD) Market is estimated to reach at a CAGR 11.7% during the forecast period (2025-2033). AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Global Closed System Drug Transfer Devices …

Global Dysport Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, And Emerging Trends

The Business Research Company's Dysport Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- In the past few years, the Dysport market has …

Buscar Company Acquires 70% Stake in Armorgenix

Buscar Company (OTCMKTS:CGLD) BEVERLY HILLS, CA, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Buscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for Growth in the U.S. Antiviral …

EcoFam Introduces Consumers to New Hydroxyapatite Toothpaste Tablets

Toothpaste Tablets Are a Sustainable, Fun, And Easy Way to Clean Your Teeth OREM, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Most Americans are used to brushing their teeth with a paste or gel dispensed from a plastic tube. Although …

Deep Brain Stimulation Devices Market estimated to reach US$3,237.249 million by 2030 at a CAGR of 10.33%

The deep brain stimulation devices market is anticipated to grow at a CAGR of 10.33% from US$1,979.749 million in 2025 to US$3,237.249 million by 2030. NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- According to a new study …

Digital Dose Inhalers Market Growth 2024 - 2031 | Insights By DataM Intelligence - Your Partner in Data-Driven Insights

The Digital Dose Inhalers Market is set for strong growth through 2031, driven by rising respiratory diseases and demand for smart, accurate drug delivery. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Digital Dose Inhalers Market …

Surgical Trocars Market Expansion Outlook 2024-2031 | DataM Intelligence – Smart Data, Smarter Decisions

The Surgical Trocars Market is set for steady growth through 2031, driven by rising demand for minimally invasive surgeries and advanced surgical tools. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Surgical Trocars Market …

Food And Beverages Market Report 2025: Size, Trends, And Growth Insights For Global Expansion

The Business Research Company’s Food And Beverages Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The food and beverages market size has grown …

Global Hydrolyzed Vegetable Proteins Market Outlook 2025-2034: Growth Drivers, Share, And Trends

The Business Research Company’s Hydrolyzed Vegetable Proteins Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The hydrolyzed vegetable proteins …

Eyewear Global Market Report 2025: Strong Market Growth Predicted With Trends and Drivers

The Business Research Company’s Eyewear Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest Report …

Stuttering Devices Market to Reach $108B by 2031, Fueled by Technology & Awareness Growth | DataM Intelligence

The future of fluent speech: Global demand for stuttering devices is reshaping therapy, tech, and accessibility. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Stuttering Devices Market is experiencing robust and sustained growth. …

Future of Diabetes Care: Tubeless Insulin Pump Market to Reach $9.65B by 2031 | DataM Intelligence

Explore the booming tubeless insulin pump market, projected to reach USD 9.65B by 2031, driven by innovation and rising global diabetes prevalence. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The tubeless insulin pump market was valued …

Nuclear Imaging Equipment Market to Reach $5.46B by 2031 Amid Rising Chronic Disease & Tech | DataM Intelligence

Nuclear Imaging Equipment Market is set to grow to $5.46B by 2031, driven by tech advances, rising chronic diseases, and expanding global healthcare needs. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Nuclear Imaging Equipment …

HbA1c Testing Device Market Set to Surge with 10.6% CAGR Through 2033 | DataM Intelligence

The HbA1c Testing Device Market, valued at US$ 2.01 billion in 2024, is projected to hit US$ 5.69 billion by 2033, growing at a CAGR of 10.6%. NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Market Overview : The HbA1c Testing Device …

Key Trend in Postpartum Depression Treatment 2025: Advancing Diagnosis And Care via Integrated Therapeutic Modalities

The Business Research Company's Postpartum Depression Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research …

Left Atrial Appendage Closure Device Market projected to surpass US$ 8,786.032 million by 2030 at a CAGR of 20.39%

The left atrial appendage closure device market is anticipated to grow at a CAGR of 20.39% from US$ 3,473.731 million in 2025 to US$ 8,786.032 million by 2030. NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- According to a new …

Leading Driver in the Posture Correction Market 2025: Surge in Spinal And Back Disorders Boosting Market Growth

The Business Research Company's Posture Correction Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Global Pressure Ulcers Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034

The Business Research Company's Pressure Ulcers Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest …